Pure Global
NCT06106685

Washed Microbiota Transplantation for Chronic Constipation in Adults

Washed Microbiota Transplantation for Chronic Constipation in Adults: a Single-center, Randomized, Double-blind, Placebo-controlled, Dose-exploring Clinical Study
The Second Hospital of Nanjing Medical University·Phase 1/2·ClinicalTrials.gov·drugRecruiting
View on ClinicalTrials.gov →
Study focus
Disease/Condition
Constipation
Drug/Device/Intervention
High-dose washed microbiota suspension
Study type
Interventional
Intervention type
drug
Sponsor & location
Primary sponsor
The Second Hospital of Nanjing Medical University
Location
Nanjing,Nanjing, China
Timeline & enrollment
Phase
Phase 1/2
Start date
Jul 24, 2023
End date
Dec 01, 2026
Enrollment
18 participants
Primary outcome

The incidence of treatment-related adverse events (AE) assessed by CTCAE, Version 5.0

Summary

This is a single-center, randomized, double-blind, placebo-controlled, dose-exploring
 clinical study to explore the safety and efficacy of washed microbiota transplantation (WMT)
 for patients with chronic constipation.

ICD-10 classifications
ConstipationIrritable bowel syndrome with predominant constipation [IBS-C]Other laxativesPoisoning: Other laxativesOther functional intestinal disorders
Data source
Registry
ClinicalTrials.gov
Trial ID
NCT06106685
Type
Non-Device Trial
About this record

Access comprehensive clinical trial information for NCT06106685 through Pure Global AI's free database. This Phase 1/2 trial is sponsored by The Second Hospital of Nanjing Medical University and is currently Recruiting. The study focuses on Constipation. Target enrollment is 18 participants.

This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.